baber/WOPTO huggingface dataset:
Patent MX-151127-A (MX)
Inventor: EILERS NORBERT
IPC: H04H20/00
Filed: 1982-04-23
Abstract: To improve reliability of recognition of an announcement recognition (AR) signal radiated by a transmitter upon broadcasting an announcement (e.g. traffic information, news, etc.) in the form of AM modulation of a 57 kHz auxiliary subcarrier, in which the subcarrier is essentially continuously modulated by region or radio-station recognition signals, the level of which changes when the announcement recognition signal is radiated, the subcarrier is filtered in the receiver, demodulated, and the degree of modulation by the frequency characteristics of the region or radio-station recognition frequency (RR) is sensed. If the modulation of the subcarrier at this frequency or frequency band (RR) drops from, for example, 60% modulation to 30% modulation, or less-a 50% level change-a switch (4) is activated which inhibits transmission of audio programs from an external source, such as a tape recorder (5), a tuner tuned to another station, or the like, and reproduces the program or announcement being broadcast by the station to which a region or radio-station recognition frequency is assigned. Termination of the AR signal (FIG. 3: t2), forming the AR modulation on the 57 kHz subcarrier, causes the switch (4) to revert for reproduction of previously controlled audio information upon increase in the level of the RR modulation on the subcarrier, which is sensed in a modulation sensing circuit or network (FIG. 2: 34-37).
Patent MX-160730-A (MX)
Inventor: KELLY THOMAS P
IPC: E21B33/035
Filed: 1983-08-17
Abstract: A subsea wellhead assembly for areas subject to iceberg scouring including an upper conductor 20 in a well bore 16 and a lower conductor 26 in the well bore with the upper end of the lower conductor being within the lower end of the upper conductor and connected thereto by a weak connection and the upper end of the lower conductor being below the maximum iceberg scour depth and means for connecting said conductors, said connecting means having sufficient strenght to withstand bending loads during drilling and being removable for installation of production equipment. Additionally production equipment in the well bore includes a block valve 40 supported within the second conductor and a production string 42 extending upward from the block valve 40 and having a weak point within the upper end of the second conductor whereby the well control is not lost by deep iceberg scouring since the production control equipment is within the second conductor which is not damaged by the scouring and the production equipment extending thereabove fails without damage to the lower control equipment of loss of the well.
Patent NZ-211591-A (NZ)
Title: Coating glass with fluorine-containing tin oxide
Inventor: HARGREAVES E
IPC: C03C17/22
Filed: 1985-03-27
Abstract: A process for production of infra red reflecting fluorine containing tin oxide coatings on flat glass comprises directing on to a hot glass surface a suspension in a carrier gas of a finely divided solid volatile inorganic tin (IV) compound, free from carbon-tin bonds, containing both chlorine and fluorine. Especially preferred tin compounds are ammonium hexahalostannates of the formula
 (NH4)2SnHal6
 wherein Hal represents halogen, and a minor atomic proportion of the halogen present is fluorine and the balance chlorine. Use of solid tin (IV) compounds in accordance with the invention gives coatings of a higher light transmission per unit thickness when compared with coatings obtained using solid organo-metallic thin compounds referred to in the prior art.
Patent NZ-222934-A (NZ)
Title: Process for continuous fractionation of fatty acid mixtures
Inventor: TRAITLER H
IPC: A61K31/19
Filed: 1987-12-15
Abstract: To enrich in biologically active polyunsaturated fatty acids a fatty substance of plant or animal origin which contains these, an inclusion complex of the fatty acids is formed with a complexant in solution and the solution is cooled by being passed through a line containing 1 to 5 scraped-surface heat exchangers, and an enriched fraction is then collected in the liquid phase. 
<??>The enriched fractions, optionally combined with glycerol and converted into a form which is appropriate to their use, can constitute nutrient, cosmetic, dermatological or pharmaceutical products or may be used as a starting material in the synthesis of dihomo-gamma-linolenic acid.
Patent NZ-229140-A (NZ)
Title: Process for the preparation of 5-amino-7-(substituted amino)-4-oxo-quinoline-3-carboxylic acids
Inventor: WEMPLE JAMES NORTON
IPC: C07D401/04
Filed: 1989-05-16
Abstract: An improved process for the preparation of 5-amino-7-(substituted-amino)-quinoline-3-carboxylic acids, having known antibacterial activity, is described wherein a 5-fluoro-7-(protected and substituted-amino)quinoline-3-carboxylic acid is converted to a 5-protected amino compound and where both protected amino groups are simultaneously removed to give the desired product.
Patent NZ-237144-A (NZ)
Title: Distillation column with hollow, porous devices surrounded by catalyst
Inventor: BUCHHOLZ MATT
IPC: B01D3/00
Filed: 1991-02-18
Abstract: A method and apparatus for concurrently catalytically reacting fluid streams and distilling the reaction product. A catalytic structure (14, 114, 214) is provided within a distillation column reactor (10, 110, 210) and comprises mass transfer devices (16, 116, 216) presenting hollow spaces and a fixed catalyst bed (17, 117, 217) formed from solid catalyst particles (18, 118, 218). The mass transfer devices (16, 116, 216) comprise interconnected gas and liquid permeable elements. The liquid phase preferentially flows along channels formed in the catalyst bed (17, 117, 217) before contacting the aforedescribed devices (16, 116, 216) for mass transfer with the vapor phase which primarily flows through the devices (16, 116, 216). <IMAGE>   <IMAGE>
Patent NZ-242661-A (NZ)
Title: Side fill sift resistant carton with multilayered end and front walls and locking flaps above tear strip on front wall
Inventor: RUEHL DENNIS JOHN
IPC: B65D5/66
Filed: 1992-05-08
Abstract: A sift-resistant, reclosable carton for granular or powdered materials. The carton is a six-sided enclosure including opposed top and bottom walls, opposing front and back walls, and opposing end walls. Each end wall is comprised of an inner layer having a top edge abutting the top wall and an outer layer. The outer layer has a horizontal tear strip thereacross. The front wall has an inner layer having a top edge abutting the top wall and an outer layer. The outer layer has a horizontal tear strip thereacross which is integral with the tear strips of the end walls, forming one continuous tear strip. A glue flap is integrally attached to the top edge of the inner layer of the front wall along substantially its full length. The glue flap has a distal attachment portion and a proximal locking portion. The two portions are joined along a full length line of weakness. The distal attachment portion is secured to the inner surface of the outer layer of the front wall above the tear strip.
Patent NZ-244842-A (NZ)
Title: Package for group of articles such as bottles formed from wraparound sleeve, and from rigid panel secured to articles and used to return empty articles
Inventor: CHAUSSADAS JEAN
IPC: B65D71/50
Filed: 1992-10-21
Abstract: A carton (10, 610) accommodating a group of articles, such as bottles (B), comprises a sleeve (12, 612) having a plurality of foldably interconnected panels and a reinforcing clip panel (14, 614) which secures the articles together in a group. A top of the carton is provided by the combination of at least one panel of the sleeve and the clip panel.
Patent NZ-245717-A (NZ)
Title: Lubricating oil comprising an ester of isotridecyl alcohol,aliphatic hydrocarbons, and a minor amount of aromatics
Inventor: HOLT GRENVILLE
IPC: C10N60/02
Filed: 1993-01-20
Abstract: This invention relates to a lubricating oil composition which has a major proportion of a biodegradable base fluid which is a blend of (a) at least one ester of isotridecyl alcohol and a mono-, di or polycarboxylic acid, and (b) at least one hydrocarbon oil which has no more than 10%w/w of aromatic hydrocarbons, the rest being aliphatic. The proportion of (a) in the blend is from 25-55%w/w. The biodegradability of the base fluid renders the composition more environmentally friendly.
Patent NZ-247431-A (NZ)
Title: Wound gel composition containing pectin
Inventor: QUEEN DOUGLAS
IPC: A61K47/38
Filed: 1993-04-19
Abstract: A hydrocolloid wound gel composition useful for cleansing an debriding wounds and having some capacity for absorbing wound exudate and a method of treating wounds comprising applying the hydrocolloid wound gel to a wound. The composition includes sodium carboxymethyl-cellulose, pectin, propylene glycol and water.
Patent NZ-248089-A (NZ)
Title: Pyrimidine derivatives, herbicidal compositions thereof
Inventor: TICE COLIN MICHAEL
IPC: A01N43/54
Filed: 1993-07-06
Abstract: A class of 6-arylpyrimidines which is useful in the control of weeds is of the general formulae: <CHEM> wherein R<2> is selected from hydrogen, halo, substituted or unsubstituted alkyl, haloalkyl, polyhaloalkyl, haloalkenyl, polyhaloalkenyl, haloalkynyl, polyhaloalkynyl, alkenyl, alkynyl, alkoxy, alkylthio, alkoxycarbonylalkyl, cyano, alkoxyalkyl, alkoxycarbonyl, cycloalkyl, aralkyl, alkylamino, dialkylamino, or dialkylaminocarbonyl group; R<3> is an alkyl, alkenyl, alkynyl, or haloalkyl group; R<5> is an alkyl, alkenyl, alkynyl, alkenynyl, or alkoxyalkyl, group; R<6> is an aryl group (e.g. aromatic ring); and X is oxygen or sulfur. R<2> and R<3> may form a fused ring.
Patent NZ-248628-A (NZ)
Title: Transformed phaffia (yeast) strains and methods and vectors used
Inventor: VAN OOYEN ALBERT JOHANNES JOSE
IPC: C12R1/645
Filed: 1993-09-09
Abstract: The present invention discloses a transformed Phaffia strain. Also disclosed are specific vectors for transforming Phaffia, preferably such vectors contain expression regulating sequences obtained from Phaffia. The present invention also discloses the use of certain marker genes in Phaffia. The invention further discloses a method for transforming Phaffia.
Patent NZ-248726-A (NZ)
Title: Pharmaceutical nanoparticles; tyloxapol adsorbed on surface as stabilizer and dispersant
Inventor: KUNE SIEGFRIED J
IPC: A61K47/34
Filed: 1993-09-21
Abstract: A composition comprising nanoparticles having tyloxapol adsorbed on the surface thereof, preferably containing a diagnostic or therapeutic agent, and most preferably including a further surface modifier associated therewith is described. A method of making such nanoparticles and a method of diagnosis comprising administering to a mammal of a contrast effective amount of particles of nanoparticles having tyloxapol adsorbed on the surface thereof is also described.
Patent NZ-249911-A (NZ)
Title: 17-(3-pyridyl) substituted steroids and use in pharmaceutical compositions
Inventor: BARRIE SUSAN ELAINE
IPC: C07J41/00
Filed: 1993-03-15
Abstract: Compounds of the general formula (1> <IMAGE> wherein X represents the residue of the A, B and C rings of a steroid, R represents a hydrogen atom or an alkyl group of 1 to 4 carbon atoms, R<14> represents a hydrogen atom a halogen atom or an alkyl group of 1-4 carbon atoms and R<15> represents a hydrogen atom or an alkyl or alkoxy group of 1-4 carbon atoms, or a hydroxy or alkylcarbonyloxy group of 2 to 5 carbon atoms or together represent an oxo or methylene group or R<14> R<15> together represent a double bond and the other R<15> represent hydrogen or alkyl of 1-4 carbon atoms, and R<16> represents a hydrogen atom or an alkyl group of 1 to 4 carbon atoms, in the form of the free bases or pharmaceutically acceptable acid addition salts, with the proviso that 17-(3- pyridyl)androsta-5,14,16-trien-3 beta -o1 and 15 beta -acetoxy-17-(3-pyridyl)androsta-5, 15,dien-3 beta -o1 and their 3-acetates and 3 beta - methoxy-17-(3-pyridyl)androst-16-ene are claimed only for use in therapy are useful for treatment of androgen-dependent disorders, especially prostatic cancer, and also oestrogen-dependent disorders such as breast cancer.
Patent NZ-270387-A (NZ)
Title: Glycopeptide antibiotic, its production and compositions thereof
Inventor: COOPER ROBIN DAVID
IPC: A61K38/00
Filed: 1995-01-24
Abstract: A new glycopeptide molecule is inserted into the antibiotic group and both components are mixed with a standard pharmaceutical carrier.
Patent NZ-302170-A (NZ)
Title: Dialkyl ethers having terminal carboxy or tetrazole groups, preparation and pharmaceutical caompositions thereof
Inventor: BISGAIER CHARLES LARRY
IPC: C07C59/315
Filed: 1996-02-05
Abstract: Dialkyl ethers lower Lp(a) and triglycerides, and elevate HDL-cholesterol, and are thereby useful for treating vascular diseases and noninsulin-dependent diabetes mellitus.
Patent NZ-326525-A (NZ)
Title: Chromosome 13-linked breast cancer susceptibility gene
Inventor: TAVTIGIAN SEAN V
IPC: C12N5/08
Filed: 1996-12-17
Abstract: The present invention relates generally to the field of human genetics.  Specifically, the present invention relates to methods and materials used to isolate and detect a human breast cancer predisposing gene (BRCA2), some mutant alleles of which cause susceptibility to cancer, in particular breast cancer.  More specifically, the invention relates to germline mutations in the BRCA2 gene and their use in the diagnosis of predisposition to breast cancer.  The present invention further relates to somatic mutations in the BRCA2 gene in human breast cancer and their use in the diagnosis and prognosis of human breast cancer.  Additionally, the invention relates to somatic mutations in the BRCA2 gene in other human cancers and their use in the diagnosis and prognosis of human cancers.  The invention also relates to the therapy of human cancers which have a mutation in the BRCA2 gene, including gene therapy, protein replacement therapy and protein mimetics.  The invention further relates to the screening of drugs for cancer therapy.  Finally, the invention relates to the screening of the BRCA2 gene for mutations, which are useful for diagnosing the predisposition to breast cancer.
Patent NZ-329311-A (NZ)
Title: use of beta-casein to inhibit infection in mammalian cells by respiratory syncytial virus
Inventor: MUKERJI PRADIP
IPC: A61K38/17
Filed: 1995-03-27
Abstract: b-Casein contained in human milk, a recombinant form of b-casein contained in human milk or hydrolysates thereof is used in the manufacture of a medicament for inhibiting the infection of mammalian cells by RSV (Respiratory Syncytial Virus). b-Casein contained in human milk, a recombinant form of b-casein contained in human milk or hydrolysates thereof is used in the manufacture of a liquid nutritional product or an infant formula also containing at least one protein not contained in human milk for inhibiting the infection of mammalian cells by RSV.  b-Casein contained in human milk, a recombinant form of b-casein contained in human milk or hydrolysates thereof is used in the manufacture of a enteral nutritional product also containing at least one protein not contained in human milk for treating and/or preventing respiratory tract infection in a mammal by inhibiting the infection of mammalian cells by RSV.
Patent NZ-334557-A (NZ)
Title: Aqueous disinfecting concentrate containing an quaternary ammonium compound and a binary surfactant system comprising a nonionic surfactant and an amphoteric surfactant
Inventor: LU ROBERT ZHONGI
IPC: C11D3/37
Filed: 1999-03-09
Abstract: The aqueous disinfecting and cleaning concentrate comprises: a)	a disinfecting effective amount of quaternary ammonium compound having germicidal properties; b)	a mitigating effective amount of a binary surfactant system which includes both a polymeric alkylene oxide block copolymer nonionic surfactant and at least one amphoteric surfactant selected from alkylampho(mono- or di-)acetate compounds c)	0.1-10%wt. of a further nonionic surfactant; d)	0-3%wt. of a polyquaternary ammonium salt based polymeric cationic surfactant; e)	0-3%wt. of a builder; f)	optionally up to 5%wt. of one or more additives selected from pH adjusting agents, pH buffers, non-aqueous solvents, perfumes, perfume carriers, optical brighteners, colouring agents, opacifying agents, hydrotropes, antifoaming agents, viscosity modifying agents, enzymes, anti-spotting agents, anti-oxidants and anti-corrosion agents and g)	water up to 100%wt of the composition.
Patent NZ-338075-A (NZ)
Title: Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP PED5) for the treatment of sexual dysfunction
Inventor: BUNNAGE MARK EDWARD
IPC: A61P11/00
Filed: 1998-04-10
Abstract: Compounds of formulae (IA) and (IB) or pharmaceutically or veterinarily acceptable salts thereof, or pharmaceutically or veterinarily acceptable solvates of, wherein: R1 is C1 to C3 alkyl substituted with C3 to C6 cycloalkyl, CONR5R6 or a N-linked heterocyclic group; (CH2)nHet or (CH2)nAr; R2 is C1 to C6 alkyl; R3 is C1 to C6 alkyl optionally substituted with C1 to C4 alkoxy; R4 is SO2NR7R8; R5 and R6 are each independently selected from H and C1 to C4 alkyl optionally substituted with C1 to C4 alkoxy, or, together with the nitrogen atom to which they are attached, form a 5- or 6-membered heterocyclic group; R7 and R8, together with the nitrogen atom to which they are attached, form a 4-R10-piperazinyl group; R10 is H or C1 to C4 alkyl optionally substituted with OH, C1 to C4 alkoxy or CONH2; Het is an optionally substituted C-linked 5- or 6-membered heterocyclic group; Ar is optionally substituted phenyl; and n is 0 or 1. These compounds are potent and selective cGMP PDE5 inhibitors useful in the treatment of, inter alia, male erectile dysfunction and female sexual dysfunction.
Patent NZ-501166-A (NZ)
Title: Reverse hydroxamate-containing compounds and their use as inhibitors of matrix metalloproteinases
Inventor: HOLMS JAMES H
IPC: C07D237/14
Filed: 1998-07-27
Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or prodrug thereof, wherein: A is H; n is zero; R1 and R3 are independently H or alkyl; R2 and R4 are independently H; alkyl; alkenyl; alkoxyalkyl; alkoxycarbonylalkyl; haloalkyl; hydroxyalkyl; (alkylene)-S(O)p-alkyl; phenyl; phenylalkoxyalkyl; phenylalkyl; phenoxyalkyl; -(alkylene)-N(R5)S02-phenyl; (heterocycle)oxyalkyl; -(alkylene)-S(O)p-heterocycle; -(alkylene)-heterocycle; or -(alkylene)-NR6R7 or R1 and R2, taken together with the carbon atom to which they are attached form a ring selected from spiroalkyl of 3 to 8 carbon atoms and tetrahydropyranyl; or R3 and R4, taken together with the carbon atom to which they are attached, form a spiroalkyl group of 3 to 8 carbon atoms; or R1 and R3 taken together with the carbon atoms to which they are attached are a 5, 6, or 7-membered carbocyclic ring; X is -0-; -NR5S02-; -S(O)p-; or -C(O)-; wherein each group is drawn with its left-hand end being the end which attaches to the alkylene group and its right-hand end being the end which attaches to Ar1; Ar1 is optionally substituted phenyl; Y is a covalent bond, -O-, alkylene, piperidinyl, alkenylene of two carbon atoms, alkynylene of two carbon atoms, -S(0)p- or -C(O)-; and Ar2 is an optionally substituted aryl group selected from the group consisting of phenyl; pyridyl; pyrazinyl; pyridazinyl; furyl; thienyl; isoxazolyl; oxazolyl; thiazolyl and isothiazolyl; All other variables are as defined in the specification. A pharmaceutical composition comprising the compound of formula (I) and a pharmaceutically acceptable carrier is also described. The compound of formula (I) is used for inhibiting matrix metalloproteinases in mammals.
Patent NZ-501662-A (NZ)
Title: Valve for aerosol container with seal comprising polytetrafluoroethane (PTFE)
Inventor: RIEBE MICHAEL THOMAS
IPC: F16K24/00
Filed: 1998-07-27
Abstract: The valve for an aerosol container comprises a valve body (1) defining an aperture, a seal (9) mounted at the aperture, and a valve stem (7) having a dispensing passage (15), the valve stem (7) being slideably moveable through the seal (9) such that in a first position the valve is closed to prevent the substance to be dispensed from entering the dispensing passage (15), and in a second position the valve is opened to allow the substance to be dispensed through the dispensing passage (15). The seal (9) is made from a material comprising a fluorine-containing polymer, such as polytetrafluoroethane, ethylenetetrafluoroethylene, perfluoroalkoxyalkane, fluorinated ethylenepropylene, polyvinyldienefluoride and chlorinated ethylene tetrafluoroethylene.
Patent NZ-502279-A (NZ)
Title: 3,6-Polyhydroxybutylpyrazines useful in the treatment of diabetes
Inventor: MIGNANI SERGE
IPC: C07D241/12
Filed: 1998-07-15
Abstract: A pyrazinyl derivative or its stereoisomers, cis or trans isomers or salts thereof has the formula (I) wherein: A) R9 and R10 each are -CH2OH and either: a) R3 is -CH2-, R4 is -CHOH- and one of R1, R2, R5 and R6 are -CO-, -CH2-, -CHF-, -CH(NHR7)- or -CH(OR8)-; and the others are each -CHOH-; b) R2 and R5 each are -CHOH-, R3 is -CH2- and R1, R4 and R6 are each -CO-, -CH2-, -CHF-, -CH(NHR7)- or -CH(OR8)-; c) R1 and R6 are each CHOH-, R3 is -CH2- and R2, R4 and R5 are each -CO-, -CH2-, -CHF-, -CH(NHR7)- or -CH(OR8)-; d) R1, R4, R5 and R6 are each -CHOH- and -R2-R3- are -CH=CH- or B) R1, R2, R4, R5 and R6 are each -CHOH, R3 is -CH2-, R9 and R10 are each -CH2F or -CH2OH provided that both R9 and R10 are not -CH2OH; R7 is H, alkyl, -CO-alkyl, -CO-aryl or CO-Het and R8 is alkyl, -alkyl-COOH or -alkyl-OH. A pharmaceutical composition thereof is useful in treating or preventing diabetes and complications of diabetes.
Patent NZ-505492-A (NZ)
Title: Synthetic polysaccharides and pharmaceutical compositions thereof, useful for preventing/treating pathologies associated with a coagulation dysfunction
Inventor: BASTEN JOHANNES
IPC: A61K31/715
Filed: 1999-01-13
Abstract: Synthetic polysaccharide in acidic form and the pharmaceutically acceptable salts thereof are described, where the anionic form of the polysaccharide corresponds to one of formulae (I) to (V). Also described are pharmaceutical compositions that comprise a polysaccharide as described above. Also described is the use of a polysaccharide (as described above) for the treatment or prevention of pathologies associated with a coagulation dysfunction. Also described is the use of a polysaccharide (as described above) for the treatment or prevention of cardiovascular system disorders, thromboembolic disorders associated with arteriosclerosis and with diabetes, or thromboembolic disorders associated with rethrombosis after thrombolysis, with infarction, with dementia of ischaemic origin, with peripheral arterial diseases, with haemodialysis or with auricular fibrillations, or alternatively during the use of aorto-coronary bridge vascular prostheses.
Patent NZ-507195-A (NZ)
Title: Inducible alphaviral gene expression system
Inventor: NIEBA LARS
IPC: C07K14/18
Filed: 1999-03-25
Abstract: A DNA molecule comprising a polynucleotide, which encodes an RNA molecule comprising: (a) at least one cis-acting sequence element, (b) a first open reading frame having a nucleotide sequence encoding a non-cytopathic, temperature-sensitive RNA-dependent RNA polymerase, and (c) at least one second nucleotide sequence selected from the group consisting of : (i) a second open reading frame encoding a protein, either erythropoietin or human beta interferon. The second open reading frame is in a translatable format after one or more RNA-dependent RNA replication events; (ii) a sequence complementary to all or part of the second open reading frame of (i); and (iii) a sequence encoding an untranslated RNA molecule, or complement thereof.
Patent NZ-509285-A (NZ)
Title: Use of tiludronic acid and derivatives thereof for preventing and treating osteoporosis in poultry
Inventor: BARDON THIERRY
IPC: A61P19/10
Filed: 2001-01-09
Abstract: The use of tiludronic acid for preventing and treating osteoporosis in poultry.